Phagocyte impotence caused by an invasive bacterial adenylate cyclase - PubMed (original) (raw)
Phagocyte impotence caused by an invasive bacterial adenylate cyclase
D L Confer et al. Science. 1982.
Abstract
For unknown reasons, humans infected with the bacterium Bordetella pertussis are exceptionally vulnerable to secondary infections. Bordetella species elaborate a soluble, heat-stable, and highly active adenylate cyclase. This enzyme is internalized by phagocytic cells and catalyzes the unregulated formation of adenosine 3',5'-monophosphate (cyclic AMP), thereby disrupting normal cellular function. This unusual phenomenon may explain Bordetella-induced aphylaxis and may prove to be useful for investigating a variety of cyclic AMP-governed processes.
Similar articles
- Pathogen-host jujitsu: phagocyte impotence caused by internalized bacterial adenylate cyclase.
Confer DL, Eaton JW. Confer DL, et al. Trans Assoc Am Physicians. 1982;95:1-7. Trans Assoc Am Physicians. 1982. PMID: 6304970 - Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions.
Friedman RL, Fiederlein RL, Glasser L, Galgiani JN. Friedman RL, et al. Infect Immun. 1987 Jan;55(1):135-40. doi: 10.1128/iai.55.1.135-140.1987. Infect Immun. 1987. PMID: 2878884 Free PMC article. - Effects of adenylate cyclase toxin from Bordetella pertussis on human neutrophil interactions with Coccidioides immitis and Staphylococcus aureus.
Galgiani JN, Hewlett EL, Friedman RL. Galgiani JN, et al. Infect Immun. 1988 Apr;56(4):751-5. doi: 10.1128/iai.56.4.751-755.1988. Infect Immun. 1988. PMID: 2894360 Free PMC article. - Invasive adenylate cyclase toxin of Bordetella pertussis.
Hanski E. Hanski E. Trends Biochem Sci. 1989 Nov;14(11):459-63. doi: 10.1016/0968-0004(89)90106-0. Trends Biochem Sci. 1989. PMID: 2560273 Review. - Structure-Function Relationships Underlying the Capacity of Bordetella Adenylate Cyclase Toxin to Disarm Host Phagocytes.
Novak J, Cerny O, Osickova A, Linhartova I, Masin J, Bumba L, Sebo P, Osicka R. Novak J, et al. Toxins (Basel). 2017 Sep 24;9(10):300. doi: 10.3390/toxins9100300. Toxins (Basel). 2017. PMID: 28946636 Free PMC article. Review.
Cited by
- cAMP signaling of Bordetella adenylate cyclase toxin blocks M-CSF triggered upregulation of iron acquisition receptors on differentiating CD14+ monocytes.
Ahmad JN, Sebo P. Ahmad JN, et al. mSphere. 2024 Aug 28;9(8):e0040724. doi: 10.1128/msphere.00407-24. Epub 2024 Jul 30. mSphere. 2024. PMID: 39078132 Free PMC article. - Membrane Interaction Characteristics of the RTX Toxins and the Cholesterol-Dependence of Their Cytolytic/Cytotoxic Activity.
Ostolaza H, Amuategi J. Ostolaza H, et al. Int J Mol Sci. 2024 Mar 8;25(6):3131. doi: 10.3390/ijms25063131. Int J Mol Sci. 2024. PMID: 38542105 Free PMC article. Review. - Bordetella filamentous hemagglutinin and adenylate cyclase toxin interactions on the bacterial surface are consistent with FhaB-mediated delivery of ACT to phagocytic cells.
Nash ZM, Inatsuka CS, Cotter PA, Johnson RM. Nash ZM, et al. mBio. 2024 May 8;15(5):e0063224. doi: 10.1128/mbio.00632-24. Epub 2024 Mar 27. mBio. 2024. PMID: 38534159 Free PMC article. - Discovery of a potent and selective human AC2 inhibitor based on 7-deazapurine analogues of adefovir.
Kraina P, Česnek M, Tloušťová E, Mertlíková-Kaiserová H, Fulton CJ, Davidson EK, Smith BP, Watts VJ, Janeba Z. Kraina P, et al. Bioorg Med Chem. 2023 Nov 15;95:117508. doi: 10.1016/j.bmc.2023.117508. Epub 2023 Oct 26. Bioorg Med Chem. 2023. PMID: 37931521 - Structural basis for non-canonical integrin engagement by Bordetella adenylate cyclase toxin.
Goldsmith JA, DiVenere AM, Maynard JA, McLellan JS. Goldsmith JA, et al. Cell Rep. 2022 Aug 16;40(7):111196. doi: 10.1016/j.celrep.2022.111196. Cell Rep. 2022. PMID: 35977491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources